Corynebacterium uropygiale sp. nov., isolated from the preen gland of Turkeys (Meleagris gallopavo)

Systematic and Applied Microbiology
Markus Santhosh BraunMichael Wink

Abstract

A novel species of fastidious, lipophilic, club-shaped, Gram-positive bacteria was recovered from the preen glands of healthy Turkeys (Meleagris gallopavo) from two different locations. Phylogenetic analysis of the 16S rRNA gene showed highest similarity to Corynebacterium spheniscorum DSM 44757(T) (96.8%) with a 3.2kb stretch of rpoB sharing 82.4% sequence similarity to the same species. DNA fingerprinting by ERIC-PCR and polar lipid profiles clearly differentiated the Turkey isolates from the most closely related Corynebacteria, as did MALDI-TOF MS analysis. Chemotaxonomic tests revealed the presence of corynemycolic acids with C16:0, C18:0, C18:1ω9c and tuberculostearic acid as the major cellular fatty acids. The G+C content of the type strain was 60.7 mol%. The species was susceptible to ampicillin, kanamycin A, streptomycin, amikacin, polymyxin B and vancomycin. From our results, it becomes evident that the isolated organisms represent a new species, for which the name Corynebacterium uropygiale sp. nov. is proposed. The type strain is Iso10(T) (=DSM 46817(T)=LMG 28616(T)).

References

Mar 27, 2003·International Journal of Systematic and Evolutionary Microbiology·J GoyacheJ F Fernández-Garayzábal
Aug 2, 2003·International Journal of Systematic and Evolutionary Microbiology·J GoyacheJ F Fernández-Garayzábal
Aug 2, 2003·International Journal of Systematic and Evolutionary Microbiology·J F Fernández-GarayzábalJ Goyache
Feb 27, 2004·Nucleic Acids Research·Wolfgang LudwigKarl-Heinz Schleifer
Sep 15, 2004·Journal of Clinical Microbiology·Atieh KhamisBernard La Scola
Nov 17, 2004·International Journal of Systematic and Evolutionary Microbiology·J F Fernández-GarayzábalM D Collins
Jun 6, 2006·Applied and Environmental Microbiology·Antonio M Martín-PlateroManuel Martínez-Bueno
Mar 7, 2012·Microbiology and Molecular Biology Reviews : MMBR·Beile Gao, Radhey S Gupta
Oct 3, 2012·PloS One·Timo H J Niedermeyer, Martin Strohalm
Dec 29, 2012·Applied Biochemistry and Biotechnology·Heiko PackeiserHua Zhao
Oct 18, 2013·Molecular Biology and Evolution·Koichiro TamuraSudhir Kumar

❮ Previous
Next ❯

Citations

Aug 18, 2016·International Journal of Systematic and Evolutionary Microbiology·Aharon Oren, George M Garrity
Dec 19, 2017·Microbial Ecology·Manuel Martín-VivaldiManuel Martínez-Bueno
Dec 18, 2018·International Journal of Systematic and Evolutionary Microbiology·Markus Santhosh BraunMichael Wink
Aug 28, 2020·Frontiers in Microbiology·Kasun H BodawattaMichael Poulsen
Apr 22, 2017·The Journal of Microbiology·Qiu-Li YuChang-Tian Li
Jul 10, 2021·Animal Microbiome·Priscilla A San JuanManpreet K Dhami

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

© 2022 Meta ULC. All rights reserved